Evidence map›Paper›PMID 31263531›Full record

ReviewInterface focus2019

Mesenchymal stem cell-based bioengineered constructs: foreign body response, cross-talk with macrophages and impact of biomaterial design strategies for pelvic floor disorders.

Shayanti Mukherjee, Saeedeh Darzi, Kallyanashis Paul, Jerome A Werkmeister, Caroline E Gargett

Abstract readReview
In one paragraph

Review in Interface focus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Endometrial SUSD2Journal of personalized medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shayanti MukherjeeThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.ORCID 0000-0001-9995-002X
Saeedeh DarziThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Kallyanashis PaulThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Jerome A WerkmeisterThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.
Caroline E GargettThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia.ORCID 0000-0002-3590-2077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An excessive foreign body response (FBR) has contributed to the adverse events associated with polypropylene mesh usage for augmenting pelvic organ prolapse surgery. Consequently, current biomaterial research considers the critical role of the FBR and now focuses on developing better biocompatible biomaterials rather than using inert implants to improve the clinical outcomes of their use. Tissue engineering approaches using mesenchymal stem cells (MSCs) have improved outcomes over traditional implants in other biological systems through their interaction with macrophages, the main cellular player in the FBR. The unique angiogenic, immunomodulatory and regenerative properties of MSCs have a direct impact on the FBR following biomaterial implantation. In this review, we focus on key aspects of the FBR to tissue-engineered MSC-based implants for supporting pelvic organs and beyond. We also discuss the immunomodulatory effects of the recently discovered endometrial MSCs on the macrophage response to new biomaterials designed for use in pelvic floor reconstructive surgery. We conclude with a focus on considerations in biomaterial design that take into account the FBR and will likely influence the development of the next generation of biomaterials for gynaecological applications.

Indexed as

biomaterialsforeign body reactionimmunomodulationM1M2macrophagesmesenchymal stem cellspelvic organ prolapsetissue engineering

Identifiers

PMID31263531
PMCPMC6597526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.